<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Medical Journal of the Islamic Republic Of Iran</title>
<title_fa>مجله پزشکی جمهوری اسلامی ایران</title_fa>
<short_title>Med J Islam Repub Iran</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mjiri.iums.ac.ir</web_url>
<journal_hbi_system_id>2</journal_hbi_system_id>
<journal_hbi_system_user>journal2</journal_hbi_system_user>
<journal_id_issn>1016-1430</journal_id_issn>
<journal_id_issn_online>2251-6840</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.18869/mjiri</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1385</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2006</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<volume>20</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>APROTININ: EFFECTS ON BLOOD LOSS AND FRESH FROZEN PLASMA REQUIREMENT IN CARDIAC OPERATIONS</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa>Original Research</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt; &lt;strong&gt;ABSTRACT&lt;/strong&gt;&lt;/p&gt;&lt;p&gt; &lt;strong&gt;Background:&lt;/strong&gt; Aprotinin has been used increasingly to reduce postoperative blood loss in open-heart operations due to the potentialities for complications and high cost, it would seem reasonable to use aprotinin more selectively in small doses in the prime solution of the pump.&lt;/p&gt;&lt;p&gt; &lt;strong&gt;Methods:&lt;/strong&gt; We prospectively studied the effect of preoperative low dose aprotinin [2 million units (230mg)] on blood loss and transfusion requirements in patients undergoing cardiopulmonary bypass. One-hundred and fifty patients were randomly assigned to two groups: prophylactic low dose aprotinin (group 1) and a non-medicated control group (group 2). The two groups were comparable in all demographic and operative variables.&lt;/p&gt;&lt;p&gt; &lt;strong&gt;Results:&lt;/strong&gt; Postoperative chest tube drainage was significantly decreased in the aprotinin group compared with that in the control group (372.73 mL in group 1 and 482.2 mL in group 2, p&lt;0.05). No significant difference was seen between the two groups in regard to transfusion requirement (p&gt;0.05). The use of fresh frozen plasma (FFP) was significantly less in group 1 than in group 2 (469.87 mL versus 680.69 mL, p&lt;0.05).&lt;/p&gt;&lt;p&gt; &lt;strong&gt;Conclusion:&lt;/strong&gt; Prophylactic use of low-dose aprotinin immediately before cardiopulmonary bypass reduced the need for transfusion of blood &amp; fresh frozen plasma (FFP) during the post operative period.&lt;/p&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Cardiac surgery, Aprotinin, Blood loss</keyword>
	<start_page>119</start_page>
	<end_page>121</end_page>
	<web_url>http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1-221&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>H. </first_name>
	<middle_name></middle_name>
	<last_name>TEIMOURI</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846002362</code>
	<orcid>20031947532846002362</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Shahid Madani Hospital,Lorestan University of Medical Sciences, Lorestan, Iran </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>F.</first_name>
	<middle_name></middle_name>
	<last_name> SABZI</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846002363</code>
	<orcid>20031947532846002363</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Imam Ali Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
